Show
Sort by
-
- Journal Article
- A1
- open access
Does the impact of COVID‐19 on patients with systemic sclerosis change over time?
-
- Journal Article
- A1
- open access
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis : results from the MYONET registry
(2024) RHEUMATOLOGY. -
Proposed response parameters for twelve‐month drug trial in juvenile systemic sclerosis : results of the Hamburg International Consensus Meetings
-
Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease : a EUSTAR database analysis
-
Glucocorticoids prescribing practices in systemic sclerosis : an analysis of the EUSTAR database
-
Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis From European Scleroderma Trials and Research
-
Use of platelet inhibitors for digital ulcers related to systemic sclerosis : EUSTAR study on derivation and validation of the DU-VASC model
-
Cutaneous manifestations, clinical characteristics, and prognosis of patients with systemic sclerosis sine scleroderma : data from the International EUSTAR Database
-
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database : analysis by region
-
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies : data from the EUSTAR cohort
-
- Journal Article
- A1
- open access
Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis
-
Functional disability and its predictors in systemic sclerosis : a study from the DeSScipher project within the EUSTAR group
-
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study
-
- Journal Article
- A1
- open access
The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis
-
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population